iNNO Clinical

Aperio Clinical Outcomes, formerly known as iNNO Clinical, is a clinical research organization (CRO) headquartered in Durham, North Carolina. Founded by Faye Woolf, the company provides comprehensive and customizable clinical research services across multiple therapeutic areas, with a specialized focus on oncology and rare diseases. Aperio emphasizes transparency and accountability, offering a suite of services including clinical monitoring, biostatistics, data management, and pharmacovigilance. The company is known for its "people-first" approach and its use of advanced clinical trial technologies to deliver high-quality data and insights for its life science partners. As of early 2026, the firm continues to operate as a key service provider in the Research Triangle Park innovation hub.